MDLZ

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

—

Return

—

Status

—

Subscribe to read

Outcome

✓

Return

-0.43%

Status

scored

HOLD MDLZ at ≤3% portfolio weight with active pre-committed trigger architecture; do not add capital at current $60.67 into overhead 50 SMA resistance with declining volume and unconfirmed MACD. Wait for either a pullback entry to $56-58 on volume flush and 200 SMA retest, or a confirmed breakout above $61.24 on >12M shares with MACD line crossover. Track position through Q3 2026 earnings as binary catalyst gate; prior passive Holds produced -0.87%/session alpha bleed requiring mechanical discipline.

Outcome

✗

Return

+2.17%

Status

scored

Maintain MDLZ at 3-5% portfolio weight with hard structural stop at $55.86 (not the lower Bollinger Band at $57.38, which sits inside 1 ATR and triggers on noise). Pre-committed bilateral triggers govern upgrades (close >$58.60 with MACD narrowing and RSI >45) and downgrades (close <$55.86 with volume ≥10M), plus a mandatory -1.0%/5-session alpha-loss trim if MDLZ underperforms SPY. Q2 2026 earnings is the binary event that resolves the margin recovery thesis—current 27.8% GM sits unconfirmed between the 28% deterioration threshold and 30% recovery confirmation.

Outcome

✓

Return

-0.40%

Status

scored

Maintain MDLZ at benchmark weight with a Hold rating as the calibrated synthesis where the bear case prevents a constructive stance and the bull case prevents a preemptive trim. Pre-commit three mechanical triggers: trim 10-15% of position on rallies to $60.70-$62.06 (10 EMA/50 SMA/August downtrend line), hard exit on a 2-day close below $57.17 with volume ≥10M, and optional collar (long $55 put financed by selling $62-$63 call) to monetize elevated IV into late-October Q3 2026 earnings. The 3.56% dividend yield provides carry while awaiting the binary re-rating catalyst.

Outcome

✗

Return

+1.93%

Status

scored

MDLZ rated Underweight with target to reduce to 50-70% of consumer staples benchmark weight via three-tiered trim execution (1/3 at $59.17-59.50, 1/3 at $60.00-60.40, final 1/3 on close above $61.41 with volume ≥10M); hard stop at $57.35 confirmed on 2-day close basis to filter ATR $1.15 noise. Pre-committed -1.0%/5-session alpha-loss trim trigger and mandatory full trim at current levels if no bounce materializes within 3-5 sessions. Q3 2026 earnings late October is the binary re-evaluation event.

Outcome

✓

Return

+0.52%

Status

scored

Maintain MDLZ at ≤3% of portfolio with no adds ahead of the Q3 earnings binary catalyst in late October, refining the stop from the trader's $57.35 to $56.50 (1 ATR) to prevent whipsaw while defending the structural thesis; pre-committed mechanical triggers include a bullish reclaim above $58.54 on volume ≥7M to upgrade to Overweight, a bearish confirmation below $57.35 to trim to Underweight, and an automatic 5% trim if MDLZ underperforms SPY by -1.0% over any 5-session rolling window.

Outcome

✗

Return

+0.74%

Status

scored

MDLZ rated Underweight at 85-90% benchmark weight via tiered execution—initial 10-15% trim at $57.82 now, second 10-15% trim staged on any relief bounce to $59-60, with hard structural stop at $56.80. Pre-committed -1.0%/5-session alpha-loss trim trigger converts discretion into discipline per binding 9/22 and 9/24 lessons; Q3 2026 earnings (late October) is the binary re-evaluation event where consensus 23% EPS growth faces downside risk from 27% operating income collapse and margin compression.

Outcome

–

Return

-0.10%

Status

scored

Trim MDLZ to 85-90% of benchmark weight on rallies to $60.70 or $62.06, with a hard stop at $58.20, based on a multi-tier technical breakdown, 27% operating income collapse, and 490bps gross margin compression; pre-commit to an automatic -1.0%/5-session alpha-loss trim trigger and position for asymmetric downside into Q3 2026 earnings as the binary resolution catalyst.

Outcome

✗

Return

-2.53%

Status

scored

MDLZ warrants an Overweight rating with 50% of target weight deployed immediately at $60.10-$60.50 via market orders, reserving the remaining 50% for scaled conditional adds on weakness toward the lower Bollinger test at $59.50 and 200 SMA test at $58.95-$59.05, with hard stop at $58.80 (defending the 200 SMA at $58.93); a mandatory alpha-loss trim trigger fires automatically if MDLZ underperforms SPY by -1.0% over any 5-session rolling window, converting the binding 9/24 procedural failure lesson into pre-committed discipline rather than discretionary hesitation.

Outcome

✓

Return

-1.43%

Status

scored

MDLZ is rated Underweight at 85-90% of consumer staples benchmark weight (a modest ~10-15% reduction), with a hard structural stop at $58.50 and a pre-committed alpha-loss trim trigger: if MDLZ underperforms SPY by -1.0% over any 5-session rolling window, automatically trim an additional 5% into strength. Re-engagement requires either a close above $62.10 (50 SMA) on volume ≥10M with MACD positive and RSI >50, or capitulation add-on at $58.50-$58.93 with RSI divergence and MACD histogram compressing toward zero. The Q3 2026 earnings (late October) is the binary resolution event for this position.

Outcome

✓

Return

-0.12%

Status

scored

Maintain MDLZ at neutral sizing with a HOLD rating, defended by the $58.50 structural stop just below the 200 SMA. The key execution refinement is a pre-committed, tightened alpha-loss trim trigger: if MDLZ underperforms SPY by -1.0% over any 5-session rolling window, automatically trim 15% of the position. Bull re-engagement to Overweight requires two consecutive closes above the 10 EMA at $61.19 with RSI reclaiming 50; bear confirmation triggers a trim-to-Underweight on a close below $58.50 on above-average volume. Collect the 3.42% dividend carry over the 4-6 week time horizon through Q3 2026 earnings.

Outcome

✗

Return

-1.00%

Status

scored

Maintain MDLZ at 75-100% of target weight while collecting the 3.39% dividend yield as carry. The structural 200 SMA floor at $58.85 has defended for 42+ sessions and hard stop $58.50 remains intact, but short-term momentum is broken with MACD at -0.20 and price below all major moving averages, providing no directional confirmation for a rating change.

Outcome

✗

Return

-0.94%

Status

scored

MDLZ holds at $61.44 in a congestion zone with balanced risk/reward (downside to June/July lows ~5.7-6.2% vs. upside to 52W high ~5-8%), lacking the confirmation needed for an upgrade or downgrade. The 200 SMA at $58.80 has defended for 42+ sessions and TTM operating margin recovered to 22.0%, supporting a structural floor, while Q1 2026 gross margin of 27.8% trails 2025's 28.4%, contradicting the cocoa inflection thesis. HOLD is the highest expected-value path through Q3 2026 earnings, with explicit upgrade triggers (2-day close >$62.00 with positive MACD + volume ≥10M) and downgrade triggers (close <$60.17 with MACD <-0.30).

Outcome

✓

Return

+0.59%

Status

scored

MDLZ maintains a HOLD rating with a $58.50 stop loss protecting the 200 SMA structural floor at $58.82, while the prior 9/21 trim producing +1.5% alpha binds against further reduction and broken short-term momentum (10 EMA below 50 SMA, MACD histogram at -0.20) prevents aggressive additions. The framework includes a mandatory alpha-loss trim trigger of -2% underperformance vs SPY over 10 sessions to prevent silent alpha bleed, scaled entry tranches only on confirmed basing evidence, and Q3 2026 earnings as the next binary catalyst in late October.

Outcome

✗

Return

+1.51%

Status

scored

Reduce existing MDLZ position to 75% of target weight (trim 25%), with no new exposure at any level. The trader's $62.00 stop equals entry price and is rejected in favor of a $58.50 structural stop just below the 200 SMA. Re-engagement requires confirmed close above $62.00 on volume of at least 10M with MACD histogram positive; downgrade to Sell on confirmed close below $58.50.

Outcome

✓

Return

-1.12%

Status

scored

Underweight MDLZ with a 30-40% staged trim (lighter than the 50-70% trader proposal) executed on rallies into $61.95-$62.50 and $63.50 resistance, preserving partial exposure given the intact 200 SMA floor at $58.76 and defensive 3.35% yield. Hard structural stop at $58.50, with re-engagement to Hold above $63.50 on volume ≥10M with positive MACD histogram; Q3 2026 earnings in late October serves as the binary catalyst window.

Outcome

✗

Return

-1.92%

Status

scored

MDLZ holds at neutral weight as the structural floor at $58.56 and 3.34% dividend yield argue against trimming, while volume distribution weakness and declining institutional interest on rallies argue against adding. The position should maintain benchmark weight or modestly below, reinvest dividends, and wait for technical resolution above $65.00 or below $60.67 before adjusting.

Outcome

✓

Return

-0.51%

Status

scored

Maintain MDLZ as a HOLD with no incremental capital deployment. The structural floor (200 SMA at $58.56, 3.35% dividend, brand portfolio) is intact, but tactical setup is neutral-to-mildly-bearish with MACD negative for 18 sessions, price range-bound near lower Bollinger Band at $60.66, and hawkish Fed compressing dividend multiples. No laddered adds until technical confirmation: close above $64.74 on volume ≥10M with MACD histogram positive. Stop at $60.50; trim toward $64.50-$64.70 on rallies.

Outcome

✓

Return

+0.42%

Status

scored

MDLZ warrants HOLD despite intact structural thesis (22% TTM operating margin recovery, golden cross with 50 SMA at $61.74 above 200 SMA at $58.59, 3.33% dividend yield) because three tactical signals argue against adding: the $64.74 Bollinger upper band has capped four advances and represents hardened resistance, MACD has been persistently negative for ~18 sessions, and MDLZ has underperformed both the S&P (+2.8% vs +12.1%) and consumer staples sector over 6 months; prior Underweight outcome (-0.5% return, -0.05% alpha) confirms that directional conviction on quality compounders with intact floors generates structurally capped alpha.

Outcome

–

Return

-0.46%

Status

scored

MDLZ earns an Underweight rating with a recommended ~30% trim of existing position, tranched over 1-2 weeks to manage near-term volatility risk given Bollinger compression (ATR compressed from $1.80 to $1.36). The bear case is validated by three independent deterioration signals—coordinated technical breakdown (1.7:1 negative skew), zero Q1'26 buybacks vs $1.52B in Q1'25, and a structural gross margin regime at 27.8% (490bps below Q2 2025)—while the 200 SMA at $58.56 provides a defensible structural floor and the 30% trim preserves defensive ballast against the 94% Polymarket no-cut 2026 recession tail-risk.

Outcome

–

Return

-0.08%

Status

scored

MDLZ is rated Underweight with a staged trim to 50–70% of benchmark weight over 1–2 weeks, executing roughly one-third at current levels ($62.40–$62.80) and reserving two-thirds for any retest of the $63.50–$64.70 resistance zone; hard stop at $58.56 (200 SMA). The bear case rests on Q1→Q2 gross margin contraction (160bps sequential), negative dividend coverage ($2.25B FCF vs ~$2.5B annual payouts), and a premium 22.87x PE valuation in a CPG sector facing GLP-1 secular headwinds and EU regulatory pressure. Rotate freed capital to short-duration Treasuries at 4.5%+; do not rotate into GIS as it faces the same category risks. Re-engage on close above $64.82 with volume ≥8M and positive MACD histogram; downgrade to Sell on close below $58.56 with volume ≥8M. Q3 2026 earnings late October is the binary catalyst.

Outcome

✓

Return

-0.05%

Status

scored

Maintain MDLZ as a defensive 3% ballast position with dividend reinvestment; avoid adding fresh capital at current ~$62-63 levels where forward P/E of 18.58x offers no margin of safety. Scale in only on confirmed pullback to the 50 SMA zone ($60.40–$61.70), with hard stop at $60.40 and additional tranches contingent on defended 200 SMA test at $58.52.

Outcome

–

Return

+0.08%

Status

scored

Execute a tranched 30-35% trim of MDLZ over 1-2 weeks given confirmed structural deterioration signals (MACD bearish cross, zero buybacks in Q1'26 vs $1.52B in Q1'25, Net Debt/EBITDA expansion to ~3.8x), with target position size of 60-65% of benchmark weight and hard stop at $57.50. The rating is Underweight rather than full Sell because fair value is $50-55 (13-20% downside), the 200 SMA at $58.48 provides a genuine structural floor, and the brand portfolio (Oreo, Cadbury, Toblerone) represents irreplaceable franchise value.

Outcome

✗

Return

+1.28%

Status

scored

Maintain MDLZ at 3% defensive ballast with a hard stop at $58.44 (200 SMA) and a tactical warning at $60.62 — tighten to $59.50 if price closes below $60.62 on volume >8M without breaking the 200 SMA. Collect the 3.39% dividend through the Q3 earnings binary catalyst (late October), when upgrade to Overweight triggers above $64.99 on volume >12M or downgrade to Underweight triggers below $58.44 on volume >8M.

Outcome

✗

Return

+0.57%

Status

scored

MDLZ faces confirmed deterioration across technical (failed $65 retests, MACD bearish cross), fundamental (zero Q1'26 buybacks vs $1.52B in Q1'25, Net Debt/EBITDA expansion to ~3.9x), and structural channels (18.2x P/E embeds 23% undelivered EPS recovery). The one-third trim monetizes the structural underweight signal while preserving the 3.38% dividend yield, 0.40 beta ballast, and brand portfolio floor; stop loss set at $58.40 (200 SMA) with re-engagement triggers at $66.65 or breakdown below $58.30.

Outcome

✗

Return

-0.28%

Status

scored

MDLZ warrants a 25-33% weight reduction via tranched execution (~50% near $62.50-$63.00, ~50% reserved for $63.50-$64.70 resistance retest), with the stop revised to $65.00 (1.5 ATR) instead of the structurally incoherent $66.50 level. Four-quarter sequential EPS contraction of 30%, zero Q1'26 buybacks versus $1.52B in Q1'25, and Net Debt/EBITDA expansion to ~3.8x support the underweight call, while the $58.28 200 SMA provides a hard exit floor for residual positions.

Outcome

✓

Return

-1.60%

Status

scored

Trim MDLZ by 25-30% via tranched execution over 1-2 weeks, selling ~15-20% into any retest of the $62.50-$62.85 zone and reserving ~10% for a confirmed break of the 50 SMA at $61.38 on volume ≥8M, with the trader's stop revised to $64.75 (1.5 ATR) to avoid whipsaw; maintain meaningful residual exposure for dividend, beta ballast, and intact structural floor through the Q3 earnings catalyst in late October.

Outcome

✗

Return

+1.36%

Status

scored

Trim MDLZ by 30% immediately at market, with a conditional tiered trigger to add another 15-20% of original position on a daily close below $60.94 (lower Bollinger Band). Set a hard stop at $57.50 on the residual position, sized to 1.0-1.5% of total portfolio risk. Re-engagement requires either a confirmed close above $66.65 on volume ≥8M with RSI >60, or a defended pullback into $54-55 with margin stabilization confirmation.

Outcome

–

Return

-0.74%

Status

scored

Upgraded from Hold to Underweight with a measured trim to 75-80% of benchmark weight, executing on extensions into the $63.50-64.50 resistance zone rather than chasing current levels; retain remainder with a non-negotiable stop at $60.50 and hard exit below $58.28. Three deteriorating signals (expanding negative MACD histogram at -$0.19, 82.6% D/E with 40% interest expense increase since 2022, and 3.34% dividend yield losing to ~4% 10-year Treasury) justify the measured underweight positioning through Q3 2026 earnings as the re-evaluation catalyst.

Outcome

–

Return

-0.47%

Status

scored

Analysts unanimously recommend trimming approximately one-third of MDLZ exposure over 2–4 weeks, executing ~60% into the $64–$65 resistance zone if strength emerges and ~40% at market, with a residual stop at $65.85. The underweight call is driven by management pausing all share repurchases at near-YTD highs, a technically deteriorating setup with MACD histogram flipping negative and price below the 10 EMA, and a forward PE of 18.55x that embeds an unrealistic 23% EPS recovery against the stock's structural 3–5% growth profile.

Outcome

–

Return

-0.11%

Status

scored

Trim MDLZ to 75-80% of benchmark weight (not aggressive 60%) over 8-12 trading sessions, with 30-40% of trim initiated before Jackson Hole Aug 28-30; revise stop from $65.10 to $61.50 (just above 50 SMA at $61.31), with close below $61.31 on volume ≥8M escalating to 60% benchmark weight and hard exit at $58.24 (200 SMA) break.

Outcome

✓

Return

-0.92%

Status

scored

Maintain MDLZ position with tighter stop at $60.80 (below 50 SMA with breathing room) while preserving neutral weight through Q3 earnings; contingent add on breakout above $64.77 with volume ≥8M shares and MACD re-crossing confirmation, contingent trim on defended close below 50 SMA with MACD continuing to roll. The structural floor ($5B capital return program, 0.40 beta insurance, Oreo/Cadbury moat) supports passive Hold over measured trim given prior lesson base rate shows defensive action at this configuration generates inconsistent and modest alpha at best.

Outcome

–

Return

+0.03%

Status

scored

MDLZ warrants a measured trim of 25-30% given deteriorating momentum (RSI rolled from 66 to 52, MACD compressed 87% from peak), structural concerns including Q1 net income down 9% YoY despite 8.3% revenue growth and debt-funded capital returns at 150% payout ratio, and an 18.7x forward P/E not compensating for elevated uncertainty; retain 70-75% position with $61.16 (50 SMA) structural stop and hard exit below $58.17 (200 SMA), parking freed capital in short-duration Treasuries at ~4.5% yield until either a confirmed breakout above $66.65 on volume ≥8M with RSI >60, or a defended pullback into $60.92-$58.17 with positive internals.

Outcome

✗

Return

-2.64%

Status

scored

Maintain MDLZ position with disciplined execution at current levels; avoid chasing at $64-$65 and preemptive trimming. Execute optional 5-7% trim only on confirmed rejection at $65.08 (close back below with declining volume within 1-2 sessions), and add only on confirmed breakout above $66.65 with volume ≥10M and RSI >60, or pullback into $60-$62 zone with positive internals. Q3 2026 earnings in late October serves as the binary catalyst for gross margin validation.

Outcome

–

Return

+0.39%

Status

scored

Trim MDLZ to 60-70% of normal defensive staple weight over the next 1-2 weeks, executing primarily on rallies into the $64.50-$64.83 upper Bollinger Band resistance zone, retaining the remaining position with a structural stop at $61.20 (50 SMA) and a hard exit at $58.07 (200 SMA); freed capital should rotate into short-duration Treasuries at ~4.5% yield awaiting either a confirmed breakout above $66.65 on ≥8M volume with RSI >60 or a pullback to the $58-60 zone with volume capitulation confirmation, with full reassessment at Q3 2026 earnings in late October.

Outcome

–

Return

+0.48%

Status

scored

Trim 15-20% of MDLZ exposure on any extension into the $64.50-$64.83 upper Bollinger Band resistance zone while retaining 80-85% of the position with a structural stop at $61.16 (50 SMA). The decision maintains the Underweight thesis through measured reduction rather than aggressive exit, balancing the constructive technical structure against real FCF coverage concerns and consensus EPS credibility issues. Reassess at Q3 2026 earnings late October as the binary catalyst, with re-engagement triggers at $66.65 breakout or $58-59 flush-and-hold.

Outcome

✓

Return

-0.03%

Status

scored

Maintain MDLZ at $64.76 with Hold rating as the Aug 18 topping pattern has time-decayed without resolution, suggesting the distribution thesis is failing. The $61.16 (50 SMA) structural stop remains the key risk level, with escalation to Underweight triggered only on confirmed close below $61.09 on volume. Reassess at Q3 2026 earnings late October as the binary catalyst for margin recovery validation.

Outcome

✗

Return

+2.39%

Status

scored

Trim 30% of MDLZ at current $62.50 over 2-4 weeks in the $62-63 exit zone while retaining 70% of the position with a structural stop at $59.88, as the Aug 17 Hold's explicit 1-2 week escalation threshold has passed without the required breakout above $64.61 or defended flush to $61.07-$60.50 with positive internals—park freed capital in 4.5% short-duration Treasuries or hold as dry powder for the next high-conviction setup.

Outcome

✓

Return

+0.77%

Status

scored

Maintain MDLZ at Hold with the lighter-touch framework that has generated alpha across four of the last five calls, but with elevated escalation discipline: if the topping pattern extends another 1-2 weeks without a confirmed close above $64.61 on volume ≥7M with RSI >55 OR a defended flush to $61.07-$60.50 with positive internals, trim toward the conservative analyst's 30-40% range. The risk-reward math from $62.18 to $57.92 stop ($4.26/6.85% downside) versus $66-67 target ($3.82-$4.82/6.1-7.7% upside) is roughly symmetric, not the 4.5:1 asymmetric ratio claimed, which collapses the aggressive initiation case.

Outcome

✗

Return

-2.25%

Status

scored

Maintain MDLZ at $63.61 with the 75-85% core exposure intact—do not add at current levels, do not trim preemptively. Trim 25% only on a confirmed move to the $66.50–$67.00 supply zone (July 29 spike high), and add 25% only on a flush to $58–60 with volume capitulation exceeding 10M shares; hard stop sits at $55 with structural review triggered on close below $57.90 (200 SMA).

Outcome

–

Return

+0.13%

Status

scored

Trim approximately 25% of MDLZ at $63.53 (below upper Bollinger band at $64.42, RSI 58.93, MACD flat at +0.04) while maintaining a 75-85% core position, with a structural stop at $57.88 (200 SMA) rather than the tighter $60.74 (10 EMA minus 1 ATR) to avoid whipsaw in this 0.40-beta defensive name; re-engage on confirmed breakout above $66.65 on volume ≥10M shares or on a flush into the $58.00-$59.00 zone holding the 200 SMA.

Outcome

✗

Return

+2.17%

Status

scored

Maintain MDLZ at $62.18 with the $59.30 capital-preservation stop intact and do not add at current levels — the 18.5x forward P/E (PEG 1.02) has already priced in the consensus $3.36 EPS recovery with symmetric ~$4.50 upside versus ~$4.32 downside risk. Wait for either a pullback to the 50 SMA at $60.92 with RSI resetting into 48-50 and MACD histogram turning positive, or a confirmed breakout above $64.20 on volume ≥12M shares with RSI >60 before considering any partial add at half-normal sizing.

Outcome

✓

Return

+0.65%

Status

scored

Maintain MDLZ at $61.53 with HOLD rating; the 18.4x forward P/E offers no margin of safety at 1.02 PEG, and 94% MACD histogram erosion signals momentum risk, but the 50 SMA at $60.87 has held for three months and the 3.25% yield makes holding cost-effective. Allow an optional ≤25% scale-in tranche on either a close above $62.10 with MACD histogram > +0.10 or a flush to $60.50–$60.87 with bullish reversal structure, with $58.50 stop-loss intact and re-evaluation at Q3 2026 earnings (late October).

Outcome

✓

Return

+0.41%

Status

scored

Maintain MDLZ exposure at current levels without adding; the $62.75 add threshold requires volume confirmation (>7M shares) and a daily close reclaim of the 10 EMA, while the $57.84 level serves as a lower add zone only with confirmed reversal structure on >6M shares. Tighten stops on existing longs to $60.00 on a daily-close basis, with re-evaluation anchored to Q3 earnings in late October as the validation catalyst for the recovery thesis.

Outcome

✓

Return

-1.72%

Status

scored

Analysts recommend trimming ~30% of MDLZ exposure at $62.50 to preserve capital given that consensus has priced in a ~75% EPS rebound at 18.6x forward earnings (requiring five positive outcomes), while MACD histogram decayed 72% in eight sessions and volume collapsed from 20M to 5M. Retain a core defensive position for beta 0.40 protection and the 3.19% dividend, with stops at $58.20 and re-entry triggers at $58.20 on confirmed support with MACD expansion or above $66.65 on volume ≥15M with MACD histogram re-expanding.